Consolidated Edison, Inc., through its subsidiaries, provides electric, gas, and steam utility services in the United States.
The company is a dividend aristocrat as well as a component in the S&P 500 index. Over the past 10 years Consolidated Edison has delivered an average total return of 7.30% annually to its loyal shareholders. Dividends have accounted for the majority of this return. Historically, the best time to buy ED was on dips and dividend yield of over 6%.
The company has managed to deliver an unimpressive 1.50% average annual increase in its EPS since 1998.
The ROE has been decreasing from over 12% 1999 to a little over 7% 2004, before recovering slightly to 10% in 2007.
Annual dividend payments have increased over the past 10 years by an average of 1% annually, which is slightly below the growth in EPS. A 1% growth in dividends translates into the dividend payment doubling every 72 years. If we look at historical data, going as far back as 1979, ED has actually managed to double its dividend payments on average every fourteen years.
If we invested $100,000 in ED on December 31, 1997 we would have bought 2421 shares. Your first quarterly check would have amounted to $1283 in early 1998. If you kept reinvesting the dividends though instead of spending them, your quarterly dividend income would have risen to $2356 by November 2007. For a period of 10 years, your quarterly dividend has increased by 9.40 %. If you reinvested it though, your quarterly dividend would have increased by 83.60%.
The dividend payout has fluctuated greatly, along with the EPS and ROE. The current ratio of 67% does look a little high. When put into the perspective of the past 10 year’s average of 77.50 % though, it looks pretty normal for the company. Overall, a lower payout is always a plus, since it leaves room for consistent dividend growth minimizing the impact of short-term fluctuations in earnings.
ED is a slow growing utilities company, which does offer a generous yield. The best time to purchase the stock over the past 10 years has been on dips and higher than average yields.
I do like the fact that the company is trading at a low multiple and has been able to consistently raise its dividends for over 34 consecutive years. I would require a yield of at least 6% however in order to initiate a position in the stock. If you are retiring in less than 10 years, you could buy a half position at current prices and then buy a second half below $39. I would be a buyer on dips below $39.
Full Disclosure: I do not own shares of ED
- Wal-Mart Dividend Analysis
- 3M Dividend Analysis
- Procter & Gamble Dividend Analysis
- Sherwin Williams Dividend Analysis
I have built my portfolio of dividend growth stocks over the past 8 – 9 years, by following a disciplined approach to investing . Having an...
Each week, I go through the list of dividend increases in order to monitor performance of existing holdings, and uncover hidden dividend ge...
This is a guest post written by Ben Reynolds at Sure Dividend . Sure Dividend helps individual investors build high quality dividend gro...
This is a guest post by Mike, aka The Dividend Guy. He authors The Dividend Guy Blog since 2010 and manages portfolios at Dividend Stocks ...
Each week I review the list of dividend increases . This is helpful in monitoring existing dividend holdings, and monitoring the breadth of ...
Over the past week, we have seen some crazy turbulence in stock prices. When I saw S&P 500 futures down by 5% on Election Day, I was n...
HCP, Inc. (HCP) is a real estate investment trust that invests in properties serving the healthcare industry including sectors of healthcare...
Regular readers know that I have assets held in taxable and non-taxable accounts . Taxable account provide me with more flexibility in th...
A dividend king , is a company that has managed to boost dividends to shareholders every single year for at least 50 years in a row. There a...
CVS Health Corporation (CVS), together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmac...